Prevalence and characterization of the mechanisms of macrolide, lincosamide and streptogramin resistance in viridans group streptococci

International Journal of Antimicrobial Agents

Volumn 22, Issue 6, 2003, Pages 626-629

  Ioannidou, Sofia ^a,b   Papaparaskevas, Joseph ^b   Tassios, Panayotis T ^b   Foustoukou, Maria ^a   Legakis, Nicholas J ^b   Vatopoulos, Alkiviadis C ^b  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Class A erm gene; Macrolides; mefA, ermB; Viridans streptococci

Indexed keywords

ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE;

ADOLESCENT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILD; ERM GENE; GENETIC ANALYSIS; HUMAN; INFANT; MEFA GENE; NONHUMAN; OROPHARYNX; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SALIVARIUS; STREPTOCOCCUS SANGUINIS;

EID: 0345549421     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.05.001     Document Type: Article

References (23)

1. Bryskier A. Viridans group streptococci: a reservoir of resistant bacteria in oral cavities. Clin. Microbiol. Infect. 8:2002;65-69.
2. Amsden G.W. Pneumococcal macrolide resistance - myth or reality. J. Antimicrob. Chemother. 44:1999;1-6.
3. Efstratiou A. Group A streptococci on the 1990s. J. Antimicrob. Chemother. 45:(Suppl.):2000;3-12.
4. Aracil B., Minabres M., Oteo J., Torres C., Gomez-Garces J.L., Alos J.I. High prevalence of erythromycin-resistant and clindamycin-susceptible (M phenotype) viridans group streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria. J. Antimicrob. Chemother. 48:2001;592-594.
5. Ioannidou S., Tassios P.?, Kotsovili-Tseleni A., Foustoukou M., Legakis N.J., Vatopoulos A.C. Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children. Int. J. Antimicrob. Agents. 17:2001;195-201.
6. Wu J.J., Lin K.Y., Hsueh P.R., Liu J.W., Pan H.I., Sheu S.M. High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob. Agents Chemother. 41:1997;844-846.
7. Widjojoatmodjo M.N., Fluit A.C., Verhoef J. Rapid identification of bacteria by PCR single-strand conformation polymorphism. J. Clin. Microbiol. 32:1994;3002-3007.
8. Luna V.A., Coates P., Eady A., Cove E.A., Nguyen T.T., Roberts M.C. A variety of Gram-positive bacteria carry mobile mef genes. J. Antimicrob. Chemother. 44:1999;19-25.
9. Roberts M.C., Chung W.O., Roe D., Xia M., Marguez C., Borthagaray G., et al. Erythromycin-resistant Neisseria gonorrheae and oral commensal Neisseria spp. carry known rRNA methylase genes. Antimicrob. Agents Chemother. 43:1999;1367-1372.
10. Kataja J., Huovinen P., Skurnik M., Seppalla H. Erythromycin resistance genes in group A streptococci in Finland. Antimicrob. Agents Chemother. 43:1999;48-52.
11. Roberts M.C., Sutcliffe J., Courvalin P., Jensen L.B., Rood J., Seppalla H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:1999;2823-2830.
12. King A., Bathgate T., Phillips I. Erythromycin susceptibilitiy of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin. Clin. Microbiol. Infect. 8:2002;85-92.
13. Perez-Trallero E., Vicente D., Montes M., Marimon J.M., Pineiro L. High proportion of pharyngeal carriers of commensal streptococci resistant to erythromycin in Spanish adults. J. Antimicrob. Chemother. 48:2001;225-229.
14. Rodriguez-Avial I., Rodriguez-Avial C., Culebras E., Benitez A., Picazo J.J. Distribution of mef(A) and erm(B) genes in macrolide resistant blood isolates of viridans group streptococci. J. Antimicrob. Chemother. 47:2001;727-728.
15. Ono T., Shiota S., Hirota K., Nemoto K., Tsuchiya T., Miyake Y. Susceptibilities of oral and nasal isolates of Streptococcus mitis and Streptococcus oralis to macrolides and PCR detection of resistance genes. Antimicrob. Agents Chemother. 44:2000;1078-1080.
16. Jacobs J.A., van Baar G.J., London N.H., Tjhie J.H., Schouls L.M., Stobberingh E.E. Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ('S. milleri') group. Antimicrob. Agents Chemother. 45:2001;2375-2377.
17. Arpin C., Canron M.H., Maugein J., Quentin C. Incidence of mefA and mefE genes in viridans group streptococci. Antimicrob. Agents Chemother. 43:1999;2335-2336.
18. Syrogiannopoulos G.A., Grivea I.N., Fitoussi F., Doit C., Katopodis G.D., Bingen E., et al. High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children. Pediatr. Infect. Dis. J. 20:2001;863-868.
19. Tzelepi E., Kouppari G., Mavroidi A., Zaphiropoulou A., Tzouvelekis L. Erythromycin resistance amongst group A beta-haemolytic streptococci isolated in a paediatric hospital in Athens Greece. J. Antimicrob. Chemother. 43:1999;745-746.
20. Ioannidou S., Tassios P.T., Zachariadou L., et al. In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibility. Clin. Microbiol. Infect. 9:2003;704-707.
21. Zachariadou L., Papaparaskevas J., Paraskakis I., et al. Predominance of two M-types among erythromycin-resistant group A streptococci from Greek children. Clin. Microbiol. Infect. 9:2003;310-314.
22. Lipsitch M., Samone M.H. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg. Infect. Dis. 8:2002;347-354.
23. Reig M., Galan J.C., Baquero F., Perez-Diaz J.C. Macrolide resistance in Peptostreptococcus spp. mediated by class A erm: possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes. Antimicrob. Agents Chemother. 45:2001;630-632.